Firstsource Solutions deal momentum and AI-led margins reinforce FY27 growth outlook
Firstsource Solutions Ltd.
BUY
₹285
₹264.75
₹340
19.30%
Investment View
ICICI Direct Research maintains a BUY recommendation on Firstsource Solutions with a target price of Rs 340, compared with a CMP of Rs 285. The target is based on 21 times FY28E EPS. The broker highlights strong deal momentum, AI-led delivery transformation and continued margin expansion as the core earnings drivers.
Firstsource Solutions provides business process services to BFSI, communication, media, technology and healthcare clients. It serves more than 200 global clients, including several Fortune 500 and FTSE 100 companies.
Q1 FY27 Financial Performance
In Q1 FY27, revenue was US$288 million, increasing 1.8% sequentially and 11.2% year-on-year in US dollar terms. Constant-currency revenue grew 2.2% sequentially and 12.3% year-on-year. Rupee revenue stood at Rs 2,724.9 crore, up 5.5% sequentially and 22.9% year-on-year.
According to management, this marked the ninth consecutive quarter of double-digit year-on-year revenue growth. EBIT margin expanded by about 20 basis points sequentially and 110 basis points year-on-year to 12.4%, marking the seventh consecutive quarter of margin expansion. EBITDA margin was 16.6%.
| Q1 FY27 metric | Reported performance |
|---|---|
| US dollar revenue | US$288 million; up 1.8% sequentially and 11.2% year-on-year |
| Constant-currency revenue growth | Up 2.2% sequentially and 12.3% year-on-year |
| Rupee revenue | Rs 2,724.9 crore; up 5.5% sequentially and 22.9% year-on-year |
| EBIT margin | 12.4%; up 20 basis points sequentially and 110 basis points year-on-year |
| EBITDA margin | 16.6% |
Exceptional Items and Reported PAT
Reported Q1 FY27 PAT was Rs 165.9 crore, down 19.2% sequentially and 2% year-on-year, due to exceptional items totalling Rs 71.7 crore. These comprised:
- A Rs 35.7 crore provision for estimated non-recoverable dues following termination of a healthcare BPaaS client contract.
- Rs 28.4 crore of indemnification for a regulatory penalty payable to a healthcare client due to contractual non-fulfilment.
- A Rs 7.6 crore fair-value adjustment on contingent consideration from an earlier acquisition.
The company indicated that the first two items are largely recoverable and non-recurring.
Deal Momentum and Growth Outlook
The operating outlook is supported by four large deal wins with annual contract value above US$5 million and 12 new logos in Q1 FY27. Three of the new logos are strategic and have potential annual revenue run-rates of at least US$5 million.
Firstsource Solutions recorded its sixth consecutive quarter with at least four large deals, its highest annual contract value intake in four quarters and a pipeline exceeding US$1 billion.
Management retained FY27 constant-currency revenue-growth guidance of 10% to 13%, including approximately 9.5% organic growth, despite the healthcare BPaaS wind-down that was expected to contribute 1% to 1.5% to growth. Management expects add-on work from the same client, large-deal ramp-ups, new logos and a stronger second half of FY27 to offset this impact. ICICI Direct expects US dollar revenue to grow at a 10.2% CAGR over FY26 to FY28E.
Segment and Geographic Performance
The United States accounted for 66% of revenue and declined 0.6% sequentially. The UK and EMEA accounted for 32% of revenue and grew 5.4%, supported by increased offshore and nearshore adoption.
| Business segment | Q1 FY27 performance | Key drivers or factors |
|---|---|---|
| BFSI | Up 5% sequentially and 14% year-on-year in constant currency | Demand for intelligent operations, financial crime, compliance, collections and AI-enabled servicing |
| Healthcare | Down 2% sequentially and up 11% year-on-year in constant currency | Programme timing and the BPaaS exit |
| CMT | Up 9% sequentially and 6% year-on-year in constant currency | Growth in the communication, media and technology business |
Margin Expansion and Estimates
Management reiterated FY27 EBIT-margin guidance of 12.25% to 12.75% and its target of 14% to 15% over the next two to three years, despite continued investment in AI capabilities, new growth engines and partnerships.
ICICI Direct attributes the margin progress to delivery optimisation, AI-led productivity, right-shoring and disciplined execution. The broker estimates EBIT margins of 12.4% for FY27E and 12.6% for FY28E.
| Broker estimate or revision | Assessment |
|---|---|
| FY27E revenue | Raised by 1.1% |
| FY27E EBIT | Raised by 1.0% |
| FY27E PAT | Cut by 6.6% to Rs 908 crore |
| FY27E diluted EPS | Cut by 6.6% to Rs 12.9 |
Key Risks
- Delayed recovery of exceptional items: ICICI Direct identifies delayed recovery of the exceptional items related to the healthcare BPaaS client as a key risk.
- Pipeline conversion and growth execution: Slower pipeline growth or weaker conversion of deals could affect the growth outlook.
- Guidance execution: The broker notes that execution may track the mid to lower end of management guidance.
Recommendation and Valuation
ICICI Direct maintains its BUY recommendation and Rs 340 target price, based on 21 times FY28E EPS. The broker continues to view deal momentum, AI-led productivity and margin expansion as supportive of the FY27 growth outlook, while recognising the risks around exceptional-item recovery, deal conversion and execution against guidance.
Disclaimer: This is a summary of a research report published by the broker/research house identified above. The views, recommendations, target prices and estimates are those of the respective broker and do not represent DSIJ investment advice. The summary may be AI-assisted, hence please refer to the original report for complete details, disclosures and risks.
